From November 14-15, 2024, the 4th Point of Care Africa International Colloquium was held in Cape Town, South Africa. Global experts, scholars, and industry leaders gathered to discuss the practical applications and future advancements of POCT technology. As a key partner of the conference, Wondfo hosted a dedicated forum on the applications of POCT in precision and primary healthcare. The company also showcased its glycated hemoglobin (HbA1c) and coagulation POCT solutions, drawing significant attention from professional attendees.
 
Unlimited Potential of POCT
 
The forum titled “POCT in Primary Care”. Wondfo invited multiple experts and scholars to deliver insightful presentations. “Rapid and accurate diagnosis improves patient outcomes,” emphasized Dr. T. Pillay, a professor at Wits Medical School, Johannesburg, during his keynote speech on “POCT Troponins and Their Impact in Diagnosing Myocardial Infarction” He highlighted the critical role of troponin POCT testing in identifying myocardial infarction.


 
Prof. A. Zemlin from Stellenbosch University explored the evidence of POCT for HbA1c in diabetes management, presenting clinical cases and research that demonstrated how it can help primary care physicians optimize blood glucose control strategies. Prof. G. Davison from Cardio-Metabolic Health Research Unit, Cape Town, delved into the application of POCT in coagulation testing and monitoring, particularly for patients on anticoagulant therapy. Prof. Z. Chapanduka, also from Stellenbosch University, discussed the Point of Care in diagnostic hematology, including the miniaturization of devices and the exploration of new biomarkers.
 
Diverse Technology Platforms and Product Lines

Wondfo highlighted its latest achievements in HbA1c and coagulation testing during the event, engaging in in-depth discussions with experts about primary healthcare testing solutions. Wondfo also shared the advantages of POCT in improving diagnostic efficiency, combating infectious diseases, and optimizing antibiotic use in primary care settings.

At the colloquium, healthcare professionals from various African institutions had the opportunity to experience the ease of operating Wondfo's instruments. Many expressed eagerness to implement POCT solutions in emergency departments and mobile laboratories. “These user-friendly devices are well-suited for non-laboratory professionals, such as nurses,” one expert remarked.
 


With over 30 years of expertise in IVD industry, Wondfo has built an extensive portfolio of technology platforms and product lines. These solutions cater to a wide range of primary healthcare needs, including chronic disease management, maternal and child health, respiratory illnesses, and infectious diseases. The devices are designed for simplicity and deliver rapid results, meeting the urgent demands of point-of-care testing in primary care settings.
 
In response to the growing demand for digital diagnostics, Wondfo has developed a robust intelligent management system for POCT, enabling real-time quality control, data management, and visualization. “This system allows even remote healthcare facilities to connect and operate under unified management,” an expert affirmed during the event.
 


As a leading POCT company from China, Wondfo was invited to participate in a roundtable discussion alongside experts, university representatives, and industry leaders. The company shared its insights into reducing the costs of POCT product adoption and its innovative practices in collaboration with industrial, academic, and professional organizations.
 
“It is an honor to share our expertise and innovative technologies on such an influential platform. Through strategic partnerships, we aim to address diagnostic challenges and improve patient outcomes.”
 


Racing for Life, Wondfo is committed to working with industry professionals to promote the accessibility and affordability of POCT solutions in Africa, contributing to better healthcare for all.